KR970061887A - 치환된 티오페닐알케닐카복실산 구아니디드, 이의 제조방법, 약물 및 진단제로서의 이의 용도 및 이를 함유하는 약제 - Google Patents

치환된 티오페닐알케닐카복실산 구아니디드, 이의 제조방법, 약물 및 진단제로서의 이의 용도 및 이를 함유하는 약제 Download PDF

Info

Publication number
KR970061887A
KR970061887A KR1019970004337A KR19970004337A KR970061887A KR 970061887 A KR970061887 A KR 970061887A KR 1019970004337 A KR1019970004337 A KR 1019970004337A KR 19970004337 A KR19970004337 A KR 19970004337A KR 970061887 A KR970061887 A KR 970061887A
Authority
KR
South Korea
Prior art keywords
compound
formula
substituted
carbon atoms
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019970004337A
Other languages
English (en)
Korean (ko)
Inventor
얀-로베르트 슈바르크
요아힘 브렌델
하인츠-베르너 클레만
한스 요헨 랑
안드레아스 바이헤르트
우도 알부스
볼프강 숄츠
Original Assignee
야코비, 루츠 파우
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야코비, 루츠 파우, 훽스트 아크티엔게젤샤프트 filed Critical 야코비, 루츠 파우
Publication of KR970061887A publication Critical patent/KR970061887A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019970004337A 1996-02-15 1997-02-14 치환된 티오페닐알케닐카복실산 구아니디드, 이의 제조방법, 약물 및 진단제로서의 이의 용도 및 이를 함유하는 약제 Ceased KR970061887A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19605610A DE19605610A1 (de) 1996-02-15 1996-02-15 Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19605610.1 1996-02-15

Publications (1)

Publication Number Publication Date
KR970061887A true KR970061887A (ko) 1997-09-12

Family

ID=7785491

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970004337A Ceased KR970061887A (ko) 1996-02-15 1997-02-14 치환된 티오페닐알케닐카복실산 구아니디드, 이의 제조방법, 약물 및 진단제로서의 이의 용도 및 이를 함유하는 약제

Country Status (29)

Country Link
US (1) US5756535A (enExample)
EP (1) EP0790245B1 (enExample)
JP (1) JP4402747B2 (enExample)
KR (1) KR970061887A (enExample)
AR (1) AR005812A1 (enExample)
AT (1) ATE202096T1 (enExample)
AU (1) AU706554B2 (enExample)
BR (1) BR9700990A (enExample)
CA (1) CA2197628C (enExample)
CZ (1) CZ45597A3 (enExample)
DE (2) DE19605610A1 (enExample)
DK (1) DK0790245T3 (enExample)
ES (1) ES2158383T3 (enExample)
GR (1) GR3036122T3 (enExample)
HR (1) HRP970081B1 (enExample)
HU (1) HUP9700437A3 (enExample)
ID (1) ID15889A (enExample)
IL (1) IL120214A (enExample)
MX (1) MX9701163A (enExample)
NO (1) NO315424B1 (enExample)
NZ (1) NZ314230A (enExample)
PL (1) PL318412A1 (enExample)
PT (1) PT790245E (enExample)
RU (1) RU2193033C2 (enExample)
SI (1) SI0790245T1 (enExample)
SK (1) SK282440B6 (enExample)
TR (1) TR199700109A2 (enExample)
TW (1) TW445261B (enExample)
ZA (1) ZA971260B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19634229A1 (de) * 1996-08-23 1998-02-26 Basf Ag Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
EP1180029A4 (en) 1999-04-23 2002-10-02 Bristol Myers Squibb Co BICYCLIC ACYL IHIBITORING SODIUM / PROTON EXCHANGER AND RELATED PROCEDURE.
DE60220694T2 (de) 2001-10-19 2008-02-07 Toyama Chemical Co. Ltd. Alkyletherderivate oder deren salze

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
GB9012252D0 (en) * 1990-06-01 1990-07-18 Lilly Industries Ltd Pharmaceutical compounds
DE4402057A1 (de) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
DE19605610A1 (de) 1997-08-21
JP4402747B2 (ja) 2010-01-20
PT790245E (pt) 2001-10-30
EP0790245A1 (de) 1997-08-20
IL120214A0 (en) 1997-06-10
GR3036122T3 (en) 2001-09-28
ES2158383T3 (es) 2001-09-01
ZA971260B (en) 1997-08-15
CA2197628A1 (en) 1997-08-16
DK0790245T3 (da) 2001-09-03
BR9700990A (pt) 1998-09-01
CZ45597A3 (en) 1997-09-17
MX9701163A (es) 1997-08-30
SI0790245T1 (en) 2001-08-31
NO970697D0 (no) 1997-02-14
CA2197628C (en) 2006-05-16
HUP9700437A2 (hu) 1998-08-28
AU706554B2 (en) 1999-06-17
SK21397A3 (en) 1997-09-10
HRP970081A2 (en) 1998-04-30
EP0790245B1 (de) 2001-06-13
ATE202096T1 (de) 2001-06-15
RU2193033C2 (ru) 2002-11-20
TR199700109A2 (tr) 1997-09-21
HUP9700437A3 (en) 2000-03-28
HU9700437D0 (en) 1997-04-28
ID15889A (id) 1997-08-14
DE59703746D1 (de) 2001-07-19
PL318412A1 (en) 1997-08-18
HRP970081B1 (en) 2003-04-30
NO970697L (no) 1997-08-18
AR005812A1 (es) 1999-07-14
AU1265997A (en) 1997-08-21
US5756535A (en) 1998-05-26
SK282440B6 (sk) 2002-02-05
IL120214A (en) 2000-08-31
NZ314230A (en) 1997-12-19
NO315424B1 (no) 2003-09-01
TW445261B (en) 2001-07-11
JPH09249660A (ja) 1997-09-22

Similar Documents

Publication Publication Date Title
KR950022159A (ko) 치환된 1-옥소-1,2-디하이드로이소퀴놀리노일구아니딘 및 1,1-디옥소-2h-1,2-벤조티아지노일구아니딘, 이들의 제조방법, 약제 또는 진단제로서의 이들의 용도 및 이들을 포함하는 약제
RU2002101723A (ru) Инданилзамещенные бензолкарбонамиды, способ их получения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции
EP0113778B1 (en) Aryl substituted aminomethyl benzene derivatives useful as antiarrhythmic agents
KR950005817A (ko) 5원환을 갖는 벤조-융합된 헤테로사이클릭 화합물, 이의 제조방법, 약제로서의 이의 용도, 진단제로서의 이의 용도 및 이를 함유하는 약제
KR970025611A (ko) 치환된 설폰이미다미드, 이의 제조방법,약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
EP0114878B1 (en) Phthalazine substituted aminomethyl benzene derivatives, compositions and use
KR960000861A (ko) 퍼플루오로알킬 그룹을 갖는 페닐-치환된 알케닐카보구아니디드, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
KR910005708B1 (ko) 1,5-벤조티아제핀 유도체의 제조방법
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
JPS636058B2 (enExample)
KR960041152A (ko) 플루오로페닐-치환된 알케닐카복실산 구아니디드, 이의 제조 방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
RU2005137571A (ru) Новые производные диазабициклононена
JP2005526138A5 (enExample)
RU97109003A (ru) Замещенные 2-нафтоилгуанидины, способ их получения и лекарственное средство на их основе
KR950703949A (ko) 히드록시카르바졸 화합물의 항산화성 심장보호 용도 및 이를 이용한 치료 방법(Antioxidant Cardioprotective Use of, and Methoed of Treatment Using, Hydroxycarbazole Compounds)
KR970074776A (ko) 치환된 2-나프토일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 함유하는 약제
CZ20011807A3 (cs) Způsob výroby farmaceutického prostředku, farmaceutický prostředek a jeho použití
KR970061887A (ko) 치환된 티오페닐알케닐카복실산 구아니디드, 이의 제조방법, 약물 및 진단제로서의 이의 용도 및 이를 함유하는 약제
KR100210976B1 (ko) 항부정맥제
KR970006282A (ko) 4-플루오로알킬-치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도, 및 이를 포함하는 약제
RU98117567A (ru) Сульфонамидозамещенные хроманы, способы их получения, их применение в качестве медикаментов, а также содержащие их фармацевтические композиции
KR970074753A (ko) 치환된 1-나프토일구아니딘, 이의 제조 방법, 약물과 진단제로서의 이의 용도 및 이를 함유하는 약제
RU2208611C2 (ru) Сульфонамидозамещенные хроманы и фармацевтическая композиция
RU97109002A (ru) Замещенные 1-нафтоилгуанидины, способ их получения и лекарственное средство на их основе
KR20100067677A (ko) 스핑고신-1-포스페이트 (ｓｐ1) 생물학적 활성을 갖는 아릴 또는 헤테로아릴 기를 함유하는 인돌 화합물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19970214

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20020207

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19970214

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20040228

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20040430

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20040228

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I